26 Einträge gefunden

1. Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment

   1. Majewski, Matthäus
   2. Paffenholz, Pia
   3. Ruf, Christian
   4. Che, Yue
   5. Seidel, Christoph
   6. Heinzelbecker, Julia
   7. Schmelz, Hans-Ulrich

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Testicular germ cell tumours' clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival-a systematic review

   1. Ruf, Christian G
   2. Schmidt, Stefanie
   3. Kliesch, Sabine
   4. Oing, Christoph
   5. Pfister, David
   6. Busch, Jonas
   7. Heinzelbecker, Julia

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
3. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence

   1. Winter, Christian
   2. Zengerling, Friedemann
   3. Busch, Jonas
   4. Heinzelbecker, Julia
   5. Pfister, David
   6. Ruf, Christian
   7. Lackner, Julia

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
4. Prognostic factors in patients with clinical stage I nonseminoma—beyond lymphovascular invasion: a systematic review

   1. Zengerling, Friedemann
   2. Beyersdorff, Dirk
   3. Busch, Jonas
   4. Heinzelbecker, Julia
   5. Pfister, David
   6. Ruf, Christian
   7. Winter, Christian

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
5. Can magnetic resonance imaging replace conventional computerized tomography for follow-up of patients with testicular cancer? - A systematic review

   1. Busch, Jonas
   2. Schmidt, Stefanie
   3. Albers, Peter
   4. Heinzelbecker, Julia
   5. Kliesch, Sabine
   6. Lackner, Julia
   7. Pfister, David

   2022 - Forschungsinformationssystem des UKE - frei zugänglich
6. Correction to: Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

   1. Wiegel, Thomas
   2. Albers, Peter
   3. Bartkowiak, Detlef
   4. Bussar-Maatz, Roswitha
   5. Härter, Martin
   6. Kristiansen, Glen
   7. Martus, Peter

   2021 - Forschungsinformationssystem des UKE
7. The developmental origin of cancers defines basic principles of cisplatin resistance

   1. Skowron, Margaretha A
   2. Oing, Christoph
   3. Bremmer, Felix
   4. Ströbel, Philipp
   5. Murray, Matthew J
   6. Coleman, Nicholas
   7. Amatruda, James F

   2021 - Forschungsinformationssystem des UKE
8. Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021

   1. Fankhauser, Christian Daniel
   2. Oldenburg, Jan
   3. Albers, Peter
   4. Algaba, Ferran
   5. Bokemeyer, Carsten
   6. Boormans, Joost L
   7. Fischer, Stefanie

   2021 - Forschungsinformationssystem des UKE
9. Results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

   1. Wiegel, Thomas
   2. Albers, Peter
   3. Bartkowiak, Detlef
   4. Bussar-Maatz, Roswitha
   5. Härter, Martin
   6. Kristiansen, Glen
   7. Martus, Peter

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
10. PSMA radioligand therapy could pose infrastructural challenges for nuclear medicine:results of a basic calculation for the capacity planning of nuclear medicine beds in the German hospital sector, PSMA-Radioligandentherapie könnte Nuklearmedizin vor infrastrukturelle Herausforderungen stellen:Ergebnisse einer Basiskalkulation zur Kapazitätsplanung nuklearmedizinischer Betten im deutschen Krankenhaussektor

    1. Zippel, Claus
    2. Giesel, Frederik L
    3. Kratochwil, Clemens
    4. Eiber, Matthias
    5. Rahbar, Kambiz
    6. Albers, Peter
    7. Maurer, Tobias

    2021 - Forschungsinformationssystem des UKE
11. Termination rates and histological reclassification of active surveillance patients with low- and early intermediate-risk prostate cancer: results of the PREFERE trial

    1. Albers, Peter
    2. Wiegel, Thomas
    3. Schmidberger, Heinz
    4. Bussar-Maatz, Roswitha
    5. Härter, Martin
    6. Kristiansen, Glen
    7. Martus, Peter

    2021 - Forschungsinformationssystem des UKE - frei zugänglich
12. Reply to Andreas Boehle, Frank Kahmann, Thomas Oliver Henkel, Joerg Zimmermann and Stefan Machten's to the Letter to the editor Re:results of a randomized trial of treatment modalities in patients with low or early-intermediate risk prostate cancer (PREFERE trial)

    1. Wiegel, Thomas
    2. Albers, Peter
    3. Bartkowiak, Detlef
    4. Bussar-Maatz, Roswitha
    5. Härter, Martin
    6. Kristiansen, Glen
    7. Martus, Peter

    2021 - Forschungsinformationssystem des UKE
13. Testis cancer: some problems still remain unsolved

    1. Albers, Peter
    2. Bokemeyer, Carsten

    2017 - Forschungsinformationssystem des UKE
14. EAU Guidelines on Testicular Cancer - 2016 edition

    1. Albers, Peter
    2. Albrecht, W
    3. Algaba, Ferran
    4. Bokemeyer, Carsten
    5. Cohn-Cedermark, Gabriella
    6. Fizazi, Karim
    7. Horwich, Alan

    2016 - Forschungsinformationssystem des UKE
15. Perspectives on sipuleucel-T: Its role in the prostate cancer treatment paradigm

    1. Gulley, James L
    2. Mulders, Peter
    3. Albers, Peter
    4. Banchereau, Jacques
    5. Bolla, Michel
    6. Pantel, Klaus
    7. Powles, Thomas

    2016 - Forschungsinformationssystem des UKE - frei zugänglich
16. Keimzelltumoren des Mannes

    1. Lorch, Anja
    2. Albers, Peter
    3. Beyer, Jörg
    4. Cathomas, Richard
    5. Oing, Christoph
    6. Souchon, Rainer
    7. Stöger, Herbertq

    2016 - Forschungsinformationssystem des UKE
17. Guidelines on Testicular Cancer: 2015 Update

    1. Albers, Peter
    2. Albrecht, Walter
    3. Algaba, Ferran
    4. Bokemeyer, Carsten
    5. Cohn-Cedermark, Gabriella
    6. Fizazi, Karim
    7. Horwich, Alan

    2015 - Forschungsinformationssystem des UKE
18. Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.

    1. Heidenreich, Axel
    2. Scholz, Hans-Jörg
    3. Rogenhofer, Sebastian
    4. Arsov, Christian
    5. Retz, Margitta
    6. Müller, Stefan C
    7. Albers, Peter

    2013 - Forschungsinformationssystem des UKE
19. Active surveillance is the preferred approach to clinical stage I testicular cancer

    1. Nichols, Craig R
    2. Roth, Bruce
    3. Albers, Peter
    4. Einhorn, Lawrence H
    5. Foster, Richard
    6. Daneshmand, Siamak
    7. Jewett, Michael

    2013 - Forschungsinformationssystem des UKE
20. The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.

    1. Calabrò, Fabio
    2. Albers, Peter
    3. Bokemeyer, Carsten
    4. Martin, Chris
    5. Einhorn, Lawrence H
    6. Horwich, Alan
    7. Krege, Susanne

    2012 - Forschungsinformationssystem des UKE